1. ICH Harmonised Tripartite Guideline—Pharmaceutical Development Q8(R2); Step 4 Version August 2009.
2. Guidance for Industry—Q9 Quality Risk management; United States FDA June 2006 ICH.
3. Guidance for Industry—Q10 Pharmaceutical Quality System; United States FDA April 2009 ICH.
4. ICH Harmonised Tripartite Guideline—Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) Q11; Step 4 Version 01 May 2012.
5. Clinical Development Success Rates 2006–2015—BIO, Biomedtracker, Amplion (2016).